The global pharmaceutical industry’s reliance on chemical intermediates necessitates a robust and stable supply chain. (S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine (CAS: 132335-44-5), a vital component in the synthesis of Duloxetine hydrochloride, is a prime example of an intermediate whose market dynamics are shaped by global manufacturing capabilities and demand. As a prominent pharmaceutical chemical manufacturer, we offer insights into these crucial supply chain aspects.
China has emerged as a major hub for the production of pharmaceutical intermediates, including (S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine. Numerous manufacturers in China are engaged in its production, offering competitive pricing and significant production capacities, ranging from kilogram to multi-ton scales. This availability makes China a primary sourcing destination for companies worldwide looking to buy this intermediate.
The market for this compound is driven by the global demand for Duloxetine. As mental health awareness grows and access to effective treatments expands, the consumption of Duloxetine, and consequently its key intermediates, remains high. This consistent demand supports a stable market, though fluctuations can occur due to raw material availability, regulatory changes, and geopolitical factors.
For pharmaceutical companies, establishing a reliable supplier relationship is critical. Key considerations when selecting a supplier include not only price and lead times but also the supplier’s commitment to quality control, adherence to international standards (like GMP where applicable for intermediates), and their ability to ensure consistent product specifications, particularly regarding purity and chiral integrity.
When engaging with manufacturers, buyers often seek to secure long-term supply agreements to mitigate risks associated with market volatility. Understanding the manufacturing processes, the origin of raw materials, and the supplier's ethical and environmental practices also contributes to a resilient supply chain. NINGBO INNO PHARMCHEM CO.,LTD. is committed to transparency and reliability, ensuring that our clients receive high-quality (S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine efficiently and consistently.
In summary, the global supply chain for (S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine is dynamic, with China playing a central role. Strategic sourcing, rigorous quality assessment, and strong supplier partnerships are essential for pharmaceutical companies to ensure the uninterrupted production of vital medicines.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.